Sabapathy S, Neslusan C, Yoong K, Teschemaker A, Johansen P, Willis M. COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA. J Popl Ther Clin Pharmacol. 2018;23(2). Accessed October 17, 2025. https://www.jptcp.com/index.php/jptcp/article/view/206